Cancer Research Landon Prizes for Basic and Translational Cancer Research  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 57, 2468-2473, June 15, 1997]
© 1997 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taylor, L. S.
Right arrow Articles by Espinoza-Delgado, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taylor, L. S.
Right arrow Articles by Espinoza-Delgado, I.

Bryostatin-1 and IFN-{gamma} Synergize for the Expression of the Inducible Nitric Oxide Synthase Gene and for Nitric Oxide Production in Murine Macrophages

Lynn S. Taylor, George W. Cox, Giovanni Melillo, Maria Carla Bosco and Igor Espinoza-Delgado1

Laboratory of Experimental Immunology, Division of Basic Sciences [L. S. T., G. W. C., G. M.], Intramural Research Support Program [M. C. B., I. E-D.], Science Applications International Corp., National Cancer Institute-Frederick Cancer Research and Development Center, NIH, Frederick, Maryland 21702-1201, and Hematology/Oncology, Department of Medicine and Stanley S. Scott Cancer Center, Louisiana State University Medical Center, New Orleans, Louisiana [I. E-D.] 70112

Bryostatin-1 (Bryo) is a nontumor-promoting protein kinase C modulator that has been shown to have both in vitro and in vivo activity against several murine and human tumors. In this study, we investigated the effects of Bryo on nitric oxide production, measured as accumulated nitrite (NO2-) in culture supernatant, and inducible nitric oxide synthase (iNOS) gene expression in the murine macrophage cell line ANA-1. ANA-1 macrophages did not produce NO2- or iNOS mRNA constitutively, and very little or no NO2- or iNOS mRNA were detectable upon exposure to IFN-{gamma}. Bryo, although ineffective alone, and IFN-{gamma} synergized to produce high levels of NO2- and iNOS mRNA. The activity of Bryo was evident at a concentration of 0.1 ng/ml and reached its maximum at 1 ng/ml. The effects of Bryo were time dependent because expression of iNOS mRNA was detectable as early as 6 h and increased through 24 h. Analyses of the molecular mechanisms involved indicate that Bryo and IFN-{gamma} mainly regulate iNOS gene expression posttranscriptionally through stabilization of iNOS mRNA. Experiments designed to investigate the role of tumor necrosis factor {alpha} (TNF-{alpha}) in NO2- production by Bryo- and IFN-{gamma}-activated macrophages revealed that ANA-1 macrophages expressed low levels of TNF-{alpha} mRNA constitutively that were not augmented in the presence of IFN-{gamma}. However, Bryo alone augmented the TNF-{alpha} mRNA expression, which was only slightly increased with the addition of IFN-{gamma}. A polyclonal antibody to TNF-{alpha} was able to completely neutralize TNF-{alpha} secreted in either medium or Bryo plus IFN-{gamma}-treated cultures. Neutralizing concentrations of anti-TNF-{alpha} antibody suppressed the Bryo plus IFN-{gamma}-induced NO2- production approximately by 50%, suggesting that NO2- produced by Bryo plus IFN-{gamma}-treated ANA-1 macrophages may involve both TNF-{alpha}-dependent and TNF-{alpha}-independent mechanisms. Overall, these findings provide the first evidence that Bryo and IFN-{gamma} can synergize for the induction of NO2- production as well as iNOS gene expression and show the involvement of posttranscriptional mechanisms in the induction of iNOS mRNA.

1 To whom requests for reprints should be addressed, at Hematology/Oncology, Department of Medicine and Stanley S. Scott Cancer Center, Louisiana State University Medical Center, 1542 Tulane Avenue, New Orleans, LA 70112. Fax: (504) 568-3694.

Received 1/14/97. Accepted 4/22/97.




This article has been cited by other articles:


Home page
J. Immunol.Home page
C. S. Garcia, R. E. Curiel, J. M. Mwatibo, S. Pestka, H. Li, and I. Espinoza-Delgado
The Antineoplastic Agent Bryostatin-1 Differentially Regulates IFN-{gamma} Receptor Subunits in Monocytic Cells: Transcriptional and Posttranscriptional Control of IFN-{gamma}R2
J. Immunol., August 15, 2006; 177(4): 2707 - 2716.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
T. J. Weber, H. S. Smallwood, L. E. Kathmann, L. M. Markillie, T. C. Squier, and B. D. Thrall
Functional link between TNF biosynthesis and CaM-dependent activation of inducible nitric oxide synthase in RAW 264.7 macrophages
Am J Physiol Cell Physiol, June 1, 2006; 290(6): C1512 - C1520.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W. Wojciechowski, H. Li, S. Marshall, C. Dell'Agnola, and I. Espinoza-Delgado
Enhanced Expression of CD20 in Human Tumor B Cells Is Controlled through ERK-Dependent Mechanisms
J. Immunol., June 15, 2005; 174(12): 7859 - 7868.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
S. K. Davidson, S. W. Allen, G. E. Lim, C. M. Anderson, and M. G. Haygood
Evidence for the Biosynthesis of Bryostatins by the Bacterial Symbiont ""Candidatus Endobugula sertula"" of the Bryozoan Bugula neritina
Appl. Envir. Microbiol., October 1, 2001; 67(10): 4531 - 4537.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
S. R. Snyder, J. F. Waring, S. Z. Zhu, S. Kaplan, J. Schultz, and G. D. Ginder
A 3'-Transcribed Region of the HLA-A2 Gene Mediates Posttranscriptional Stimulation by IFN-{{gamma}}
J. Immunol., March 15, 2001; 166(6): 3966 - 3974.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R.E. Curiel, C.S. Garcia, S. Rottschafer, M.C. Bosco, and I. Espinoza-Delgado
Enhanced B7-2 Gene Expression by Interferon-gamma in Human Monocytic Cells Is Controlled Through Transcriptional and Posttranscriptional Mechanisms
Blood, September 1, 1999; 94(5): 1782 - 1789.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1997 by the American Association for Cancer Research.